Lu and colleagues. Deep venous thrombosis remains a frequent and serious vascular complication following orthopedic trauma in aging populations, prompting researchers to evaluate predictive biomarkers upon hospital arrival.
Patient Cohort and Thrombosis Incidence in Hip Fracture Admissions
The retrospective evaluation assessed 234 patients aged 60 years and older admitted with hip fractures between January 2020 and June 2023, according to the published data. Researchers performed bilateral lower extremity Doppler ultrasounds within 24 hours of admission to detect early clots. Blood samples were collected before clinicians initiated pharmacological thromboprophylaxis to ensure baseline biomarker accuracy.
Among the study population, 50 patients developed deep venous thrombosis, corresponding to an overall incidence rate of 21.4%. Patients in the thrombosis group experienced longer intervals from injury to hospital admission. Furthermore, this cohort exhibited higher concentrations of fibrinogen and C-reactive protein, alongside lower albumin levels, when compared to patients who did not develop the condition.
Did you know?
The study evaluated blood samples before any pharmacological thromboprophylaxis was administered, allowing researchers to capture uninhibited baseline inflammatory and coagulation markers upon hospital arrival.
Fibrinogen Concentrations and Independent Risk Assessment
Mean fibrinogen concentrations were significantly higher among patients who developed deep venous thrombosis compared with those who remained free of the complication, measuring 4.15±1.11 g/L versus 3.47±0.84 g/L respectively, according to the study findings. Univariate analysis demonstrated a significant association between elevated fibrinogen levels and the onset of clotting events.
Even after accounting for confounding variables such as patient age and sex, fibrinogen remained independently associated with deep venous thrombosis. When fibrinogen levels reached or exceeded 4.15 g/L, the statistical association strengthened further. Patients at or above this threshold faced a significantly elevated likelihood of deep venous thrombosis after multivariable adjustment.
Diagnostic Performance and Biomarker Comparisons
Additional statistical evaluations revealed that fibrinogen demonstrated moderate predictive performance for early vascular complications. A combined predictive model incorporating fibrinogen, C-reactive protein, and the time elapsed from injury to admission achieved the strongest discrimination capabilities in the cohort.
By contrast, D-dimer showed limited diagnostic utility in this early admission setting. Consequently, the researchers concluded that elevated fibrinogen measured shortly after admission could support early clinical risk assessment, while the clinical role of D-dimer in this specific timeframe should be interpreted cautiously.
Frequently Asked Questions
What is the primary finding regarding fibrinogen and hip fractures?
According to the study by Lu and colleagues, higher fibrinogen concentrations measured within 24 hours of hospital admission are independently associated with an increased risk of early deep venous thrombosis in older adults with hip fractures.
What was the incidence of deep venous thrombosis in the study?
The retrospective cohort study recorded a deep venous thrombosis incidence of 21.4%, with 50 out of 234 observed patients developing the complication.
Why was D-dimer found to have limited utility?
Researchers noted that D-dimer showed limited diagnostic utility specifically within the early admission timeframe, suggesting clinicians should interpret D-dimer results cautiously during initial patient evaluations.
How was patient data collected for this research?
The study evaluated 234 patients aged 60 and older using bilateral lower extremity Doppler ultrasounds performed within 24 hours of admission, alongside blood samples drawn prior to the start of pharmacological thromboprophylaxis.
Worth a look